54 participants
Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-23
- Start Date:
- 2026-09-01
- Completion:
- 2028-12-04
Conditions
- Acute Myeloid Leukaemia
- High Risk Myelodysplastic Syndrome
Interventions
- DRUG
No Results Yet